Indivior Plc Spon Company Profile (NASDAQ:INVVY)

About Indivior Plc Spon (NASDAQ:INVVY)

Indivior Plc Spon logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:INVVY
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $22.12
  • 200 Day Moving Avg: $21.98
  • 52 Week Range: $17.18 - $27.47
  • Trailing P/E Ratio: 40.54
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $1.08 billion
  • Price / Sales: N/A
  • Book Value: ($0.92) per share
  • Price / Book: -24.46
  • EBITDA: $228 million
  • Average Volume: 2,797 shs.

Frequently Asked Questions for Indivior Plc Spon (NASDAQ:INVVY)

What is Indivior Plc Spon's stock symbol?

Indivior Plc Spon trades on the NASDAQ under the ticker symbol "INVVY."

When will Indivior Plc Spon make its next earnings announcement?

Indivior Plc Spon is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Indivior Plc Spon.

Who are some of Indivior Plc Spon's key competitors?

How do I buy Indivior Plc Spon stock?

Shares of Indivior Plc Spon can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Indivior Plc Spon's stock price today?

One share of Indivior Plc Spon stock can currently be purchased for approximately $22.50.

MarketBeat Community Rating for Indivior Plc Spon (NASDAQ INVVY)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about Indivior Plc Spon and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Indivior Plc Spon (NASDAQ:INVVY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Indivior Plc Spon (NASDAQ:INVVY)
Price Target History for Indivior Plc Spon (NASDAQ:INVVY)
Analysts' Ratings History for Indivior Plc Spon (NASDAQ:INVVY)
No equities research coverage for this company has been tracked by


Earnings History for Indivior Plc Spon (NASDAQ:INVVY)
Earnings by Quarter for Indivior Plc Spon (NASDAQ:INVVY)
Earnings History by Quarter for Indivior Plc Spon (NASDAQ INVVY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2017Q4$0.35$259.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Indivior Plc Spon (NASDAQ:INVVY)

No earnings estimates for this company have been tracked by


Dividend History for Indivior Plc Spon (NASDAQ:INVVY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Indivior Plc Spon (NASDAQ:INVVY)
No insider trades for this company have been tracked by


Headline Trends for Indivior Plc Spon (NASDAQ:INVVY)
Latest Headlines for Indivior Plc Spon (NASDAQ:INVVY)
DateHeadline logoDURECT and Indivior PLC Sign a $17.5 Million Patent Purchase Agreement - October 2 at 1:04 PM logoThe 6 Medications Being Used to Tackle the Opioid Epidemic - September 22 at 6:51 PM logoIndivior Could Fall Further Once Generic Suboxone Arrives - September 13 at 3:10 AM logo Indivior Plc Spon (INVVY) Given Consensus Rating of "" by Analysts - August 13 at 2:24 PM logoIndivior Plc :INVVY-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017 - August 2 at 11:39 PM logoINDIVIOR PLC ADR 2017 Q2 - Results - Earnings Call Slides - July 28 at 4:08 AM logoIndivor's Opioid Use Disorder Drug Meets Primary Endpoint - June 22 at 1:06 PM logoIndivior Treads Forward In Opioid Addiction Market - June 5 at 11:01 PM logo3 Things In Biotech You Should Learn Today: May 31, 2017 - May 31 at 5:54 PM logoIndivior's (INVVY) CEO Shaun Thaxter on Q1 2017 Results - Earnings Call Transcript - May 4 at 11:14 AM logoINDIVIOR PLC ADR 2016 Q4 - Results - Earnings Call Slides - February 22 at 12:38 PM logo[$$] Rolls-Royce shares buoyed by Citi upgrade - February 7 at 7:14 PM logoINVVY Key statistics | INDIVIOR PLC SPON ADR EA REPR 5 Stock - Yahoo Finance - January 21 at 5:46 PM logoStates Accuse Heroin Addiction Treatment Maker Indivior of Blocking Generics - September 23 at 8:36 AM logoEuropean Markets Down Ahead of Fed Minutes - August 17 at 5:52 PM logoEuropean Markets Open Mostly Down; ASML Falls on Intel Snub - August 17 at 8:43 AM logoQuestor share tip: Sell Indivior after a wild first year on the stock market - February 18 at 1:39 PM logoIndivior lifts profits but promises last dividend for foreseeable future - February 18 at 4:26 AM



Indivior Plc Spon (INVVY) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.